Compare ADTN & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADTN | TLRY |
|---|---|---|
| Founded | 1985 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 688.9M |
| IPO Year | 1996 | 2018 |
| Metric | ADTN | TLRY |
|---|---|---|
| Price | $16.68 | $5.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $15.50 | ★ $72.33 |
| AVG Volume (30 Days) | 2.7M | ★ 3.5M |
| Earning Date | 05-04-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.83 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,083,807,000.00 | N/A |
| Revenue This Year | $11.09 | $8.79 |
| Revenue Next Year | $8.47 | $19.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 17.46 | N/A |
| 52 Week Low | $7.11 | $0.36 |
| 52 Week High | $19.98 | $15.70 |
| Indicator | ADTN | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 53.96 | 42.97 |
| Support Level | $8.45 | $5.09 |
| Resistance Level | $18.34 | $7.01 |
| Average True Range (ATR) | 1.14 | 0.21 |
| MACD | 0.15 | 0.06 |
| Stochastic Oscillator | 43.03 | 68.95 |
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions segment, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support segment, which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions. It generates the majority of its revenue from the Network Solutions segment.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.